Michael Burgess actually said...

"I want to thank everyone for joining us this morning. We are here to explore an issue that is very personal to many patients."

"I also recognize that the Food and Drug Administration must strike the right balance between ensuring public safety and granting access to new treatments."

"Today the DCCP subcommittee will focus on a massive data breach executed against Equifax, but this is just one of many recent data breaches nationwide."

"It seems we are at a crossroads when lifesaving treatments, while not yet approved, exist but patient cannot have access."